诊断学理论与实践 ›› 2024, Vol. 23 ›› Issue (01): 90-95.doi: 10.16150/j.1671-2870.2024.01.012
收稿日期:
2023-05-01
出版日期:
2024-02-25
发布日期:
2024-05-30
通讯作者:
王学锋 E-mail:wxf10339@rjh.com.cn基金资助:
YANG Hang, DAI Jing, WANG Xuefeng()
Received:
2023-05-01
Published:
2024-02-25
Online:
2024-05-30
摘要:
脓毒症以及伴随的多器官功能障碍是一组常见的临床综合征,其患病率随着人口老龄化逐年上升。全球每年发生2 000万例脓毒症,死亡率为26%。早期准确诊断脓毒症,有利于及时采取针对性的治疗策略,这是降低病死率的关键。内皮细胞是外源病原体或内源性损伤信号的早期作用对象。研究提示,内皮细胞的结构改变与功能活化在脓毒症的发生、发展中发挥重要作用。作为内皮细胞专属信号通路,血管生成素(angiopoietin, Ang)/酪氨酸激酶受体(tyrosine kinase receptor, Tie)在内皮细胞的异常激活和损伤中发挥重要作用。Ang/Tie信号通路主要包括2种位于内皮细胞中的酪氨酸激酶受体(Tie1、Tie2)和4种分泌性糖蛋白配体(Ang-1、Ang-2、Ang-3、Ang-4)。机制研究方面,Ang-1可持续性激活Tie2受体,维持细胞与细胞、细胞与基质间的相互作用,支持血管内皮细胞正常的生理功能;Ang-2是Ang-1拮抗剂,可竞争性阻断Ang-1与Tie2受体结合。脓毒症环境下,Ang-1下降,Ang-2升高,Ang-1/Ang-2的比值下降。Ang-2竞争性阻断Ang-1与可溶性Tie2受体结合,内皮细胞处于严重异常激活状态。Ang-2介导肝素酶的释放导致糖萼损伤,可引起血管通透性增加;Ang-2可促进炎症反应;Ang/Tie信号系统失调介导凝血功能障碍,Ang-2升高是弥散性血管内凝血的前哨性事件。临床病情监测方面,Ang-2>5.61 ng/mL,诊断脓毒症的灵敏度为74.36%; Ang-2持续升高,提示内皮功能难以恢复,器官发生功能性改变。早期动态监测Ang-2可用于预测脓毒症相关肺损伤、急性肾损伤。Ang-2/Ang-1比值上升、Ang1/可溶性Tie2比值下降可预测脓毒症患者90 d病死率(ROC曲线面积分别为0.787和0.704)。Ang-2和可溶性Tie-2水平下降,则提示脓毒症血浆置换有效。靶向Ang/Tie信号通路的动物实验获得一定成功,但目前临床试验未能获得有价值的结果。脓毒症相关Ang/Tie信号通路有待于进一步深入研究。
中图分类号:
杨航, 戴菁, 王学锋. 脓毒症诊治中Ang/Tie信号通路的研究进展[J]. 诊断学理论与实践, 2024, 23(01): 90-95.
YANG Hang, DAI Jing, WANG Xuefeng. Advances in the study on Ang/Tie signaling pathway in diagnosis and treatment of sepsis[J]. Journal of Diagnostics Concepts & Practice, 2024, 23(01): 90-95.
[1] | PURCAREA A, SOVAILA S. Sepsis, a 2020 review for the internistJ[J]. Rom J Intern Med, 2020, 58(3):129-137. |
[2] |
SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J]. JAMA, 2016, 315(8):801-810.
doi: 10.1001/jama.2016.0287 pmid: 26903338 |
[3] |
KORHONEN E A, LAMPINEN A, GIRI H, et al. Tie1 controls angiopoietin function in vascular remodeling and inflammation[J]. J Clin Invest, 2016, 126(9):3495-3510.
doi: 10.1172/JCI84923 pmid: 27548530 |
[4] |
TEICHERT M, MILDE L, HOLM A, et al. Pericyte-expressed Tie2 controls angiogenesis and vessel maturation[J]. Nat Commun, 2017, 8:16106.
doi: 10.1038/ncomms16106 pmid: 28719590 |
[5] | BRAUN L J, ZINNHARDT M, VOCKEL M, et al. VE-PTP inhibition stabilizes endothelial junctions by activa-ting FGD5[J]. EMBO Rep, 2019, 20(7):e47046. |
[6] | LEE S J, LEE C K, KANG S, et al. Angiopoietin-2 exa-cerbates cardiac hypoxia and inflammation after myocardial infarction[J]. J Clin Invest, 2018, 128(11):5018-5033. |
[7] | SALIMI U, MENDEN H L, MABRY S M, et al. Angiopoie-tin-1 protects against endotoxin-induced neonatal lung injury and alveolar simplification in mice[J]. Pediatr Res, 2022, 91(6):1405-1415. |
[8] | ATREYA M R, CVIJANOVICH N Z, FITZGERALD J C, et al. Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1[J]. Crit Care, 2023, 27(1):250. |
[9] |
YUAN H T, KHANKIN E V, KARUMANCHI S A, et al. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium[J]. Mol Cell Biol, 2009, 29(8):2011-2022.
doi: 10.1128/MCB.01472-08 pmid: 19223473 |
[10] | ZIEGLER T, HORSTKOTTE J, SCHWAB C, et al. Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis. J Clin Invest, 2013, 123(8):3436-3445. |
[11] | RICHTER R P, ASHTEKAR A R, ZHENG L, et al. Glycocalyx heparan sulfate cleavage promotes endothelial cell angiopoietin-2 expression by impairing shear stress-related AMPK/FoxO1 signaling[J]. JCI Insight, 2022, 7(15):e155010. |
[12] |
LUKASZ A, HILLGRUBER C, OBERLEITHNER H, et al. Endothelial glycocalyx breakdown is mediated by angiopoietin-2[J]. Cardiovasc Res, 2017, 113(6):671-680.
doi: 10.1093/cvr/cvx023 pmid: 28453727 |
[13] | DROST C C, ROVAS A, KUSCHE-VIHROG K, et al. Tie2 activation promotes protection and reconstitution of the endothelial glycocalyx in human sepsis[J]. Thromb Haemost, 2019, 119(11):1827-1838. |
[14] | 付绪哲, 柳英杰, 牛明明, 等. 脓毒症免疫抑制机制的研究进展[J]. 中国临床研究, 2023, 36(5):741-745. |
FU X Z, LIU Y J, NIU M M, et al. Research progress in immunosuppressive mechanism of sepsis[J]. Chin J Clin Res, 2023, 36(5):741-745. | |
[15] |
SMADJA D M, GUERIN C L, CHOCRON R, et al. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients[J]. Angiogenesis, 2020, 23(4):611-620.
doi: 10.1007/s10456-020-09730-0 pmid: 32458111 |
[16] |
FIEDLER U, REISS Y, SCHARPFENECKER M, et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation[J]. Nat Med, 2006, 12(2):235-239.
doi: 10.1038/nm1351 pmid: 16462802 |
[17] |
LASK A, GUTBIER B, KERSHAW O, et al. Adjunctive therapy with the Tie2 agonist Vasculotide reduces pulmonary permeability in Streptococcus pneumoniae infected and mechanically ventilated mice[J]. Sci Rep, 2022, 12(1):15531.
doi: 10.1038/s41598-022-19560-3 pmid: 36109537 |
[18] | IDOWU T O, ETZRODT V, SEELIGER B, et al. Identification of specific Tie2 cleavage sites and therapeutic modulation in experimental sepsis[J]. Elife, 2020, 9:e59520. |
[19] | 闫威威, 董思琴, 汪华学. 红细胞分布宽度与血小板计数比值对脓毒症患者预后的预测价值[J]. 安徽医学, 2022, 43(8):887-891. |
YAN W W, DONG S Q, WANG H X. The predictive value of the ratio of red blood cell distribution width to platelet count for the prognosis of sepsis patients[J]. Anhui Med J, 2022, 43(8):887-891. | |
[20] |
HIGGINS S J, DE CEUNYNCK K, KELLUM J A, et al. Tie2 protects the vasculature against thrombus formation in systemic inflammation[J]. J Clin Invest, 2018, 128(4):1471-1484.
doi: 10.1172/JCI97488 pmid: 29360642 |
[21] | SCHMAIER A A, PAJARES HURTADO G M, MANICKAS-HILL Z J, et al. Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19[J]. JCI Insight, 2021, 6(20):e151527. |
[22] | SZEDERJESI J, ALMASY E, LAZAR A, et al. The Role of Angiopoietine-2 in the Diagnosis and Prognosis of Sepsis[J]. J Crit Care Med (Targu Mures), 2015, 1(1):18-23. |
[23] |
CALFEE C S, JANZ D R, BERNARD G R, et al. Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies[J]. Chest, 2015, 147(6):1539-1548.
doi: S0012-3692(15)37209-3 pmid: 26033126 |
[24] | RICHTER R P, ZHENG L, ASHTEKAR A R, et al. Associations of Plasma Angiopoietins-1 and -2 and Angiopoie-tin-2/-1 Ratios With Measures of Organ Injury and Clinical Outcomes in Children With Sepsis: A Preliminary Report[J]. Pediatr Crit Care Med, 2020, 21(9):e874-e878. |
[25] | PRICE D R, BENEDETTI E, HOFFMAN K L, et al. Angiopoietin 2 is associated with vascular necroptosis induction in coronavirus disease 2019 acute respiratory distress syndrome[J]. Am J Pathol, 2022, 192(7):1001-1015. |
[26] | REILLY J P, WANG F, JONES T K, et al. Plasma angiopoietin-2 as a potential causal marker in sepsis-asso-ciated ARDS development: evidence from Mendelian randomization and mediation analysis[J]. Intensive Care Med, 2018, 44(11):1849-1858. |
[27] | ROSENBERGER C M, WICK K D, ZHUO H, et al. Early plasma angiopoietin-2 is prognostic for ARDS and morta-lity among critically ill patients with sepsis[J]. Crit Care, 2023, 27(1):234. |
[28] | YU W K, MCNEIL J B, WICKERSHAM N E, et al. Angiopoietin-2 outperforms other endothelial biomarkers associated with severe acute kidney injury in patients with severe sepsis and respiratory failure[J]. Crit Care, 2021, 25(1):48. |
[29] | ATREYA M R, CVIJANOVICH N Z, FITZGERALD J C, et al. Prognostic and predictive value of endothelial dysfunction biomarkers in sepsis-associated acute kidney injury: risk-stratified analysis from a prospective observational cohort of pediatric septic shock[J]. Crit Care, 2023, 27(1):260. |
[30] | FANG Y, LI C, SHAO R, et al. The role of biomarkers of endothelial activation in predicting morbidity and morta-lity in patients with severe sepsis and septic shock in intensive care: A prospective observational study[J]. Thromb Res, 2018, 171:149-154. |
[31] | KIM W Y, KWEON O J, CHA M J, et al. Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study[J]. PLoS One, 2021, 16(7):e0254167. |
[32] | KNAUP H, STAHL K, SCHMIDT B M W, et al. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers[J]. Crit Care, 2018, 22(1):285. |
[33] | HOFMAENNER D A, DAVID S. From Angiopoietin-2 to basic chemistry: differential effects of statins on endothelial homeostasis in ARDS[J]. Crit Care, 2023, 27(1):183. |
[34] |
JIANG S, LI S, HU J, et al. Combined delivery of angiopoietin-1 gene and simvastatin mediated by anti-intercellular adhesion molecule-1 antibody-conjugated ternary nanoparticles for acute lung injury therapy[J]. Nanomedicine, 2019, 15(1):25-36.
doi: S1549-9634(18)30513-6 pmid: 30193816 |
[35] | JONES R S, SMITH P S, BERG P H, et al. Efficacy and safety of LY3127804, an anti-angiopoietin-2 antibody, in a randomized, double-blind, placebo-controlled clinical trial in patients hospitalized with pneumonia and presumed or confirmed COVID-19[J]. Clin Med Insights Circ Respir Pulm Med, 2022, 16:11795484221119316. |
[1] | 王秋云, 陈影, 赵冰, 孙思磊, 杨之涛, 毛恩强, 陈尔真. Sirt1通过HNF-1α/FXR-1通路调控脓毒症肝损伤的动物研究[J]. 诊断学理论与实践, 2020, 19(03): 279-285. |
[2] | 李媛媛, 张舒, 曹波, 陆晓晔, 刘黎, 陈杰, 归茜, 徐欣晖, 吕利雄, 朱长清,. 几种感染性疾病中外周血T淋巴细胞亚群变化的检测及其临床意义研究[J]. 诊断学理论与实践, 2015, 14(04): 363-366. |
[3] | 董育玮, 陆伦根,. 血管生成素/Tie系统在血管生成中的作用[J]. 诊断学理论与实践, 2014, 13(03): 331-335. |
[4] | 马玉, 袁克俭,. 烧伤后血栓前状态的研究进展[J]. 诊断学理论与实践, 2010, 9(05): 526-528. |
[5] | 刘莉, 卢洪洲, 卢水华, 熊延青, 席秀红,. 甲型H1N1流感死亡病例四例报告[J]. 诊断学理论与实践, 2010, 9(01): 58-62. |
[6] | 张如愿, 汤耀卿,. 脓毒症时内皮细胞激活、功能障碍和损伤相关标志物的检测[J]. 诊断学理论与实践, 2009, 8(05): 552-555. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||